Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B J Roberts

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1986
In vivo and in vitro anticancer activity of the structurally novel and highly potent antibiotic CI-940 and its hydroxy analog (PD 114,721)B J Roberts, K L Hamelehle, J S Sebolt, et al.
Cancer Research|August 15, 1994
Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivoW L Elliott, B J Roberts, C T Howard, et al.
The Journal of Biological Chemistry|December 15, 1995
Ethanol induces CYP2E1 by protein stabilization. Role of ubiquitin conjugation in the rapid degradation of CYP2E1B J Roberts, B J Song, Y Soh, et al.
Cancer Research|September 11, 1975
Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structureT H Corbett, D P Griswold, B J Roberts, et al.
Investigational New Drugs|February 1, 1991
Preclinical antitumor activity of CI-973,[SP-4-3-(R)]-[1,1- cyclobutanedicarboxylato(2-)](2 methyl-1,4-butane-diamine-N,N')platinumA J Kraker, C W Moore, B J Roberts, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Cell cycle effects of trimetrexate (CI-898)K E Hook, J M Nelson, B J Roberts, et al.
Cancer Treatment Reports|October 1, 1978
Biology and therapeutic response of a mouse mammary adenocarcinoma (16/C) and its potential as a model for surgical adjuvant chemotherapyT H Corbett, D P Griswold, B J Roberts, et al.
Cancer Research|May 1, 1982
Toxicity and anticancer activity of a new triazine antifolate (NSC 127755)T H Corbett, W R Leopold, D J Dykes, et al.
Journal of Medicinal Chemistry|August 19, 1994
Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformationJ D Hoeschele, H D Showalter, A J Kraker, et al.
Advances in Enzyme Regulation|January 1, 1985
The biochemical pharmacology of CI-920, a structurally novel antibiotic with antileukemic activityR C Jackson, D W Fry, T J Boritzki, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Cancer Chemotherapy and Pharmacology|January 1, 1986
In vivo and in vitro anticancer activity of the structurally novel and highly potent antibiotic CI-940 and its hydroxy analog (PD 114,721)B J Roberts, K L Hamelehle, J S Sebolt, et al.
Cancer Research|August 15, 1994
Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivoW L Elliott, B J Roberts, C T Howard, et al.
The Journal of Biological Chemistry|December 15, 1995
Ethanol induces CYP2E1 by protein stabilization. Role of ubiquitin conjugation in the rapid degradation of CYP2E1B J Roberts, B J Song, Y Soh, et al.
Cancer Research|September 11, 1975
Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structureT H Corbett, D P Griswold, B J Roberts, et al.
Investigational New Drugs|February 1, 1991
Preclinical antitumor activity of CI-973,[SP-4-3-(R)]-[1,1- cyclobutanedicarboxylato(2-)](2 methyl-1,4-butane-diamine-N,N')platinumA J Kraker, C W Moore, B J Roberts, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Cell cycle effects of trimetrexate (CI-898)K E Hook, J M Nelson, B J Roberts, et al.
Cancer Treatment Reports|October 1, 1978
Biology and therapeutic response of a mouse mammary adenocarcinoma (16/C) and its potential as a model for surgical adjuvant chemotherapyT H Corbett, D P Griswold, B J Roberts, et al.
Cancer Research|May 1, 1982
Toxicity and anticancer activity of a new triazine antifolate (NSC 127755)T H Corbett, W R Leopold, D J Dykes, et al.
Journal of Medicinal Chemistry|August 19, 1994
Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformationJ D Hoeschele, H D Showalter, A J Kraker, et al.
Advances in Enzyme Regulation|January 1, 1985
The biochemical pharmacology of CI-920, a structurally novel antibiotic with antileukemic activityR C Jackson, D W Fry, T J Boritzki, et al.
Pageof 5